NAS150

N/A

Report date: 2023/06/14 17:45:44
NME

Base Information

Drug NameNAS150
Drug Alias NameMnTDEIPAEOL-10150NAS150NAS-150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsSupranuclear Palsy, ProgressiveIdiopathic Pulmonary FibrosisLung Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAeolus Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesNew Amsterdam Sciences IncAeolus Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSupranuclear Palsy, ProgressiveIdiopathic Pulmonary FibrosisLung Injury +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank